Correlation Between Artiva Biotherapeutics, and Commonwealth Bank

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Artiva Biotherapeutics, and Commonwealth Bank at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Artiva Biotherapeutics, and Commonwealth Bank into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Artiva Biotherapeutics, Common and Commonwealth Bank of, you can compare the effects of market volatilities on Artiva Biotherapeutics, and Commonwealth Bank and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Artiva Biotherapeutics, with a short position of Commonwealth Bank. Check out your portfolio center. Please also check ongoing floating volatility patterns of Artiva Biotherapeutics, and Commonwealth Bank.

Diversification Opportunities for Artiva Biotherapeutics, and Commonwealth Bank

-0.11
  Correlation Coefficient

Good diversification

The 3 months correlation between Artiva and Commonwealth is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding Artiva Biotherapeutics, Common and Commonwealth Bank of in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Commonwealth Bank and Artiva Biotherapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Artiva Biotherapeutics, Common are associated (or correlated) with Commonwealth Bank. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Commonwealth Bank has no effect on the direction of Artiva Biotherapeutics, i.e., Artiva Biotherapeutics, and Commonwealth Bank go up and down completely randomly.

Pair Corralation between Artiva Biotherapeutics, and Commonwealth Bank

Given the investment horizon of 90 days Artiva Biotherapeutics, Common is expected to generate 4.63 times more return on investment than Commonwealth Bank. However, Artiva Biotherapeutics, is 4.63 times more volatile than Commonwealth Bank of. It trades about 0.13 of its potential returns per unit of risk. Commonwealth Bank of is currently generating about -0.21 per unit of risk. If you would invest  460.00  in Artiva Biotherapeutics, Common on December 8, 2024 and sell it today you would earn a total of  76.00  from holding Artiva Biotherapeutics, Common or generate 16.52% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Artiva Biotherapeutics, Common  vs.  Commonwealth Bank of

 Performance 
       Timeline  
Artiva Biotherapeutics, 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Artiva Biotherapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in April 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.
Commonwealth Bank 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Commonwealth Bank of has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Artiva Biotherapeutics, and Commonwealth Bank Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Artiva Biotherapeutics, and Commonwealth Bank

The main advantage of trading using opposite Artiva Biotherapeutics, and Commonwealth Bank positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Artiva Biotherapeutics, position performs unexpectedly, Commonwealth Bank can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Commonwealth Bank will offset losses from the drop in Commonwealth Bank's long position.
The idea behind Artiva Biotherapeutics, Common and Commonwealth Bank of pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Complementary Tools

Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon